Literature DB >> 8145918

Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues.

Y Saito1, L R Sharer, L G Epstein, J Michaels, M Mintz, M Louder, K Golding, T A Cvetkovich, B M Blumberg.   

Abstract

In previous studies, using polymerase chain reaction amplification of HIV-1 genes directly from pathologic tissues of children who died with AIDS encephalopathy, we showed that the reading frame of the HIV-1 regulatory nef gene is open, suggesting that the nef protein was expressed. We now show, using immunocytochemistry and in situ hybridization with nef-specific probes in postmortem pediatric CNS tissues, that nef mRNA and protein are present in up to 20% of astrocytes in tissue sections selected for extensive histopathology. By contrast, HIV-1 structural proteins such as gag and their coding mRNAs are present in multinucleated giant cells that harbor productive infection and are the hallmark of HIV-1 infection in the CNS. These findings are consistent with the nonproductive infection of glial cells observed in vitro, and imply that HIV-1 infection of astrocytes is restricted to early regulatory gene products, of which nef is the best target as it is expressed at high levels and is membrane-anchored. In developing central nervous tissues of children, restricted and latent HIV-1 infection of astrocytes may be extensive and contribute significantly to HIV-1 neuropathogenesis.

Entities:  

Mesh:

Year:  1994        PMID: 8145918     DOI: 10.1212/wnl.44.3_part_1.474

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  117 in total

Review 1.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 2.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain.

Authors:  Tahar Babas; Daniel Muñoz; Joseph L Mankowski; Patrick M Tarwater; Janice E Clements; M Christine Zink
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  FIV and neuroAIDS.

Authors:  Howard S Fox; Tom R Phillips
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

5.  Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium.

Authors:  Lena Al-Harti; Jeymohan Joseph; Avindra Nath
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

6.  Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.

Authors:  Dorota Kaniowska; Rafal Kaminski; Shohreh Amini; Sujatha Radhakrishnan; Jay Rappaport; Edward Johnson; Kamel Khalili; Luis Del Valle; Armine Darbinyan
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ(1-42) secretion in SH-SY5Y neural cells.

Authors:  Mahfuz B Khan; Michelle J Lang; Ming-Bo Huang; Andrea Raymond; Vincent C Bond; Bruce Shiramizu; Michael D Powell
Journal:  J Neurovirol       Date:  2015-09-25       Impact factor: 2.643

Review 8.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Persistent SIV infection of a blood-brain barrier model.

Authors:  Lisa Strelow; Damir Janigro; Jay A Nelson
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

Review 10.  Where does HIV hide? A focus on the central nervous system.

Authors:  Melissa Churchill; Avindra Nath
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.